pde9 inhibitor — TargetMol Chemicals

Search Result

Search Results for " pde9 inhibitor "

All TargetMol products are for research or drug registration purposes only and cannot be used for human consumption.
We do not provide products or services to individuals.
Please comply with the intended use and do not use TargetMol products for any other purpose in violation of laws and regulations.

Compounds

Cat No.	Product Name	Synonyms	Targets
T28352	PDE9-IN-(S)-C33	(S)-C33	PDE
	PDE9-IN-(S)-C33 ((S)-C33) is a potent and selective inhibitor of PDE9 (IC50 = 11 nM). PDE9-IN-(S)-C33 can be used for central nervous system diseases and diabetes research.		PDE
T12389	PDE-9 inhibitor		Others
	PDE-9 inhibitor is used for treatment neurodegenerative diseases.		Others
T12395	PDE9-IN-1		PDE
	PDE9-IN-1 is a selective and orally bioavailable Inhibitor of PDE9A(IC50 of 8.7 nM).		PDE
T61833	Tovinontrine	IMR-687	PDE
	Tovinontrine (IMR-687) (IMR-687) is a potent and selective inhibitor of phosphodiesterase-9 (PDE9), designed to target sickle cell disease treatment. It exhibits high efficacy, with IC 50 values of 8.19 nM and 9.99 nM fo...		PDE
T81534	PDE11A4-IN-1
	PDE11A4-IN-1 (compound 23b) is a potent, selective inhibitor of PDE11A4, demonstrating an IC50 of 12 nM and exhibiting high selectivity against PDE1, PDE2, PDE7, PDE8, and PDE9 [1].
T38899	Irsenontrine	E2027,Irsenontrine
	Irsenontrine (E2027) is a selective and orally active inhibitor of phosphodiesterase 9 (PDE9), primarily used for researching neurological diseases.
T24163	IMR687	IMR-687,IMR 687
	IMR687 is a PDE9 inhibitor that slows or stops the hydrolysis of cGMP. IMR687 can be regarded as a highly promising drug against Alzheimer's for improving memory.
T39108	Irsenontrine maleate	E2027 maleate
	Irsenontrine (E2027) maleate is a selective and orally active inhibitor of phosphodiesterase 9 (PDE9). It can be utilized in the study of neurological diseases.
T61770	(R)-Irsenontrine
	(R)-Irsenontrine ((R)-E2027), the R-enantiomer of Irsenontrine, serves as a potent inhibitor of phosphodiesterase 9 (PDE9) with an inhibition concentration (IC50) of 0.041 μM, primarily utilized in the research of neurol...